HAKL, Roman, Pavel KUKLÍNEK, Marta SOBOTKOVA, Irena KRCMOVA, Pavlina KRALICKOVA, Martina VACHOVA, Jana HANZLIKOVA, Martina NOVACKOVA, Michal SVOBODA, Ingrid KOVÁČOVÁ a Jiří LITZMAN. Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema. CLINICAL AND EXPERIMENTAL ALLERGY. HOBOKEN: WILEY, 2022, roč. 52, č. 8, s. 994-997. ISSN 0954-7894. Dostupné z: https://dx.doi.org/10.1111/cea.14182. |
Další formáty:
BibTeX
LaTeX
RIS
@article{2215440, author = {Hakl, Roman and Kuklínek, Pavel and Sobotkova, Marta and Krcmova, Irena and Kralickova, Pavlina and Vachova, Martina and Hanzlikova, Jana and Novackova, Martina and Svoboda, Michal and Kováčová, Ingrid and Litzman, Jiří}, article_location = {HOBOKEN}, article_number = {8}, doi = {http://dx.doi.org/10.1111/cea.14182}, keywords = {Icatibant; C1-inhibitor; hereditary angioedema; laryngeal attacks}, language = {eng}, issn = {0954-7894}, journal = {CLINICAL AND EXPERIMENTAL ALLERGY}, title = {Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema}, url = {https://onlinelibrary.wiley.com/doi/10.1111/cea.14182}, volume = {52}, year = {2022} }
TY - JOUR ID - 2215440 AU - Hakl, Roman - Kuklínek, Pavel - Sobotkova, Marta - Krcmova, Irena - Kralickova, Pavlina - Vachova, Martina - Hanzlikova, Jana - Novackova, Martina - Svoboda, Michal - Kováčová, Ingrid - Litzman, Jiří PY - 2022 TI - Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema JF - CLINICAL AND EXPERIMENTAL ALLERGY VL - 52 IS - 8 SP - 994-997 EP - 994-997 PB - WILEY SN - 09547894 KW - Icatibant KW - C1-inhibitor KW - hereditary angioedema KW - laryngeal attacks UR - https://onlinelibrary.wiley.com/doi/10.1111/cea.14182 N2 - Hereditary angioedema (HAE) is a rare condition which manifests as repeated episodes of localized subcutaneous or submucosal oedema. Oedemas involving the upper airways carry the risk of asphyxiation and death. The aim of this study was to present our clinical experience of icatibant and C1 inhibitor use for treating HAE-1/2 laryngeal attacks (LA). To our knowledge, this is the first direct comparison of these treatment approaches for LA. ER -
HAKL, Roman, Pavel KUKLÍNEK, Marta SOBOTKOVA, Irena KRCMOVA, Pavlina KRALICKOVA, Martina VACHOVA, Jana HANZLIKOVA, Martina NOVACKOVA, Michal SVOBODA, Ingrid KOVÁČOVÁ a Jiří LITZMAN. Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema. \textit{CLINICAL AND EXPERIMENTAL ALLERGY}. HOBOKEN: WILEY, 2022, roč.~52, č.~8, s.~994-997. ISSN~0954-7894. Dostupné z: https://dx.doi.org/10.1111/cea.14182.
|